Literature DB >> 30859326

Nanomedicines for Infectious Diseases.

Admire Dube1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30859326      PMCID： PMC7039275          DOI： 10.1007/s11095-019-2603-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  11 in total

1.  In vitro Pharmacokinetic Cell Culture System that Simulates Physiologic Drug and Nanoparticle Exposure to Macrophages.

Authors:  Hilliard L Kutscher; Gene D Morse; Paras N Prasad; Jessica L Reynolds
Journal:  Pharm Res       Date:  2019-02-01       Impact factor: 4.200

2.  VirusMap: A visualization database for the influenza A virus.

Authors:  Yubin Xie; Xiaotong Luo; Zhihao He; Yueyuan Zheng; Zhixiang Zuo; Qi Zhao; Yanyan Miao; Jian Ren
Journal:  J Genet Genomics       Date:  2017-04-29       Impact factor: 4.275

Review 3.  Nanotechnology in Tuberculosis: State of the Art and the Challenges Ahead.

Authors:  Estefania Grotz; Nancy Tateosian; Nicolas Amiano; Maximiliano Cagel; Ezequiel Bernabeu; Diego A Chiappetta; Marcela A Moretton
Journal:  Pharm Res       Date:  2018-09-20       Impact factor: 4.200

4.  Co-Delivery of Ciprofloxacin and Colistin in Liposomal Formulations with Enhanced In Vitro Antimicrobial Activities against Multidrug Resistant Pseudomonas aeruginosa.

Authors:  Shaoning Wang; Shihui Yu; Yuwei Lin; Peizhi Zou; Guihong Chai; Heidi H Yu; Hasini Wickremasinghe; Nivedita Shetty; Junhong Ling; Jian Li; Qi Tony Zhou
Journal:  Pharm Res       Date:  2018-08-09       Impact factor: 4.200

Review 5.  Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines.

Authors:  Raymonde B Bekale; Su-Mari Du Plessis; Nai-Jen Hsu; Jyoti R Sharma; Samantha L Sampson; Muazzam Jacobs; Mervin Meyer; Gene D Morse; Admire Dube
Journal:  Pharm Res       Date:  2018-11-08       Impact factor: 4.200

Review 6.  Nanomedicines for Malaria Chemotherapy: Encapsulation vs. Polymer Therapeutics.

Authors:  Sindisiwe Mvango; William M R Matshe; Abideen O Balogun; Lynne A Pilcher; Mohammed O Balogun
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

7.  Formulation of Natural Oil Nano-Emulsions for the Topical Delivery of Clofazimine, Artemisone and Decoquinate.

Authors:  Cornel Burger; Marique Aucamp; Jan du Preez; Richard K Haynes; Andile Ngwane; Jeanetta du Plessis; Minja Gerber
Journal:  Pharm Res       Date:  2018-08-07       Impact factor: 4.200

8.  Aspherical and Spherical InvA497-Functionalized Nanocarriers for Intracellular Delivery of Anti-Infective Agents.

Authors:  Arianna Castoldi; Martin Empting; Chiara De Rossi; Karsten Mayr; Petra Dersch; Rolf Hartmann; Rolf Müller; Sarah Gordon; Claus-Michael Lehr
Journal:  Pharm Res       Date:  2018-12-05       Impact factor: 4.200

9.  Perspectives on West Africa Ebola Virus Disease Outbreak, 2013-2016.

Authors:  Jessica R Spengler; Elizabeth D Ervin; Jonathan S Towner; Pierre E Rollin; Stuart T Nichol
Journal:  Emerg Infect Dis       Date:  2016-06-15       Impact factor: 6.883

10.  Zika Virus Outbreak in Rio de Janeiro, Brazil: Clinical Characterization, Epidemiological and Virological Aspects.

Authors:  Patrícia Brasil; Guilherme Amaral Calvet; André Machado Siqueira; Mayumi Wakimoto; Patrícia Carvalho de Sequeira; Aline Nobre; Marcel de Souza Borges Quintana; Marco Cesar Lima de Mendonça; Otilia Lupi; Rogerio Valls de Souza; Carolina Romero; Heruza Zogbi; Clarisse da Silveira Bressan; Simone Sampaio Alves; Ricardo Lourenço-de-Oliveira; Rita Maria Ribeiro Nogueira; Marilia Sá Carvalho; Ana Maria Bispo de Filippis; Thomas Jaenisch
Journal:  PLoS Negl Trop Dis       Date:  2016-04-12
View more
  1 in total

Review 1.  Cathelicidins and defensins antimicrobial host defense peptides in the treatment of TB and HIV: Pharmacogenomic and nanomedicine approaches towards improved therapeutic outcomes.

Authors:  Prince N Dlozi; Angelina Gladchuk; Rustin D Crutchley; Nicole Keuler; Renier Coetzee; Admire Dube
Journal:  Biomed Pharmacother       Date:  2022-05-28       Impact factor: 7.419
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.